首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
【24h】

Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.

机译:5-HT2A和5-HT2C(但不是5HT1A)受体在小鼠高架迷宫测试-再测试范例中位于导水管周围灰色区域的含义。

获取原文
获取原文并翻译 | 示例
           

摘要

A single exposure to the elevated plus-maze test (EPM) increases open arms avoidance and reduces or abolishes the anxiolytic-like effect of benzodiazepines assessed during a second trial, a phenomenon defined as "one-trial tolerance" (OTT). It has been emphasized that the dorsal portion of the midbrain periaqueductal gray (dPAG) plays a role on this enhanced aversion phenomenon in maze-experienced rodents. Given that intra-dPAG injections of a wide range of serotonergic 5-HT(1A), 5-HT(2A) and 5-HT(2C) receptor agonists produce anxiolytic-like effects in maze-naive rodents, the present study examined the effects of the 5-HT(1A) receptor agonist 8-OH-DPAT (5.6 and 10.0nmol in 0.15microl) the preferential 5-HT(2A) receptor agonist DOI (2.0 and 8.0nmol in 0.1microl) and the preferential 5-HT(2C) receptor agonist MK-212 (21.2 and 63.6nmol in 0.1microl) microinjected into the dPAG prior to Trial 1 and Trial 2 on the behaviour of mice in the EPM. Test sessions were recorded and subsequently scored for anxiety-like behaviour (percentage of open arms entries and time) as well as general locomotor activity (closed arm entries). The results showed a lack of 8-OH-DPAT (5.6 and 10.0nmol) effect on the behaviour of maze-naive and maze-experienced mice, while intra-dPAG microinfusions of DOI (8nmol) reduced anxiety-like behaviour only in maze-experienced mice that had received a similar treatment prior to Trial 1. Furthermore, intra-dPAG MK-212 (63.6nmol) showed an anxiolytic-like effect on both Trial 1 and Trial 2. Importantly, these effects were observed in the absence of any significant change in closed arm entries, the parameter considered to be a valid index of locomotor activity in the plus-maze. These results support the dPAG as a crucial structure involved in the neurobiology of the OTT phenomenon as well as accounting the role of the 5-HT(2A) and 5-HT(2C) receptors located within this midbrain structure on the emotional state induced by EPM test and retest paradigm mice.
机译:在第二次试验中评估,单次暴露于高迷迷宫测试(EPM)会增加避免张开双臂的感觉,并减少或消除苯二氮卓类药物的抗焦虑样作用,这种现象被定义为“一次试验耐受性”(OTT)。有人强调说,中脑导水管周围灰色(dPAG)的背面部分在迷宫经历的啮齿动物中对这种增强的厌恶现象起着作用。鉴于dPAG内注射多种血清素5-HT(1A),5-HT(2A)和5-HT(2C)受体激动剂可在幼稚的啮齿类啮齿动物中产生抗焦虑样作用,因此本研究研究了5-HT(1A)受体激动剂8-OH-DPAT(0.15 microl中的5.6和10.0nmol),优先5-HT(2A)受体激动剂DOI(0.1microl中的2.0和8.0nmol)和优先5- HT(2C)受体激动剂MK-212(0.1微升中的21.2和63.6nmol)在试验1和试验2中微注射到dPAG中,以了解EPM中小鼠的行为。记录测试时间,随后对焦虑样行为(张开双臂的百分比和时间)以及一般的运动活动(张开双臂的分数)进行评分。结果显示,缺乏8-OH-DPAT(5.6和10.0nmol)对未使用过迷宫和有迷宫经历的小鼠的行为产生影响,而dPAG内的DOI微灌输(8nmol)仅在迷宫中降低了类似焦虑的行为。经验丰富的小鼠在试验1之前接受了类似的治疗。此外,dPAG MK-212内(63.6nmol)对试验1和试验2均表现出抗焦虑样作用。重要的是,在没有任何试验的情况下观察到了这些作用。闭合臂项的显着变化,该参数被认为是正迷宫中运动活动的有效指标。这些结果支持dPAG作为参与OTT现象的神经生物学的关键结构,并说明位于该中脑结构内的5-HT(2A)和5-HT(2C)受体对由情绪诱发的情绪状态的作用。 EPM测试并重新测试范例小鼠。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号